BEAM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $9,885,604.19

Beam Therapeutics Insider Trading History Chart

Beam Therapeutics Share Price & Price History

^$22.24

▼ -0.29 (-1.29%)

As of 05/8/2024 01:00 AM ET

Days: 30 | 90 | 365

Did You Get Your Free Bitcoin Yet?

From Crypto Swap Profits | Ad

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

Beam Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/1/2024	Amy Simon	Insider	Sell	7,157	$32.13	$229,954.41	86,590
4/1/2024	Giuseppe Ciaramella	President	Sell	4,534	$32.12	$145,632.08	169,616
4/1/2024	John M Evans	CEO	Sell	18,102	$32.13	$581,617.26	1,058,343
4/1/2024	Terry-Ann Burrell	CFO	Sell	5,446	$32.12	$174,925.52	70,137
3/28/2024	John M Evans	CEO	Sell	60,000	$33.86	$2,031,600.00	998,262
2/13/2024	Fmr Llc	Insider	Sell	1,565	$30.76	$48,139.40	2,771,913
1/31/2024	John M Evans	CEO	Sell	60,000	$25.33	$1,519,800.00	1,058,262
1/3/2024	Christine Bellon	Insider	Sell	1,907	$26.42	$50,382.94	80,495
10/30/2023	Amy Simon	Insider	Sell	3,448	$18.70	$64,477.60	65,469
10/2/2023	Christine Bellon	Insider	Sell	388	$22.85	$8,865.80	82,402
7/24/2023	Giuseppe Ciaramella	Insider	Sell	1,206	$32.01	$38,604.06	48,250
7/21/2023	Giuseppe Ciaramella	Insider	Sell	155,324	$32.06	$4,979,687.44	48,250
7/10/2023	Amy Simon	Insider	Sell	391	$30.48	$11,917.68	68,917
4/3/2023	Giuseppe Ciaramella	Insider	Sell	1,918	$30.31	$58,134.58	114,044
4/3/2023	John M Evans	CEO	Sell	5,161	$30.31	$156,429.91	1,124,472
4/3/2023	Terry-Ann Burrell	CFO	Sell	2,454	$30.31	$74,380.74	49,303
1/26/2023	Terry-Ann Burrell	CFO	Sell	1,102	$45.16	$49,766.32	31,277
1/24/2023	Terry-Ann Burrell	CFO	Sell	14,810	$45.01	$666,598.10	31,277
1/18/2023	Terry-Ann Burrell	CFO	Sell	47,195	$45.14	$2,130,382.30	31,277
12/12/2022	Giuseppe Ciaramella	Insider	Sell	51,015	$42.70	$2,178,340.50	91,462
10/31/2022	John M Evans	CEO	Sell	30,000	$46.31	$1,389,300.00	1,058,520
8/5/2022	Fmr Llc	Insider	Sell	20,326	$60.50	$1,229,723.00
7/28/2022	John M Evans	CEO	Sell	30,000	$65.75	$1,972,500.00	1,088,520
4/28/2022	John M Evans	CEO	Sell	30,000	$37.98	$1,139,400.00	1,118,520
4/13/2022	Fmr Llc	Insider	Sell	19,466	$50.41	$981,281.06
3/31/2022	Giuseppe Ciaramella	Insider	Sell	1,859	$59.11	$109,885.49	115,614
3/31/2022	John M Evans	CEO	Sell	6,261	$59.11	$370,087.71	1,089,070
3/31/2022	Terry-Ann Burrell	CFO	Sell	1,787	$59.11	$105,629.57	38,278
12/21/2021	Giuseppe Ciaramella	Insider	Sell	25,104	$85.69	$2,151,161.76
10/6/2021	John M Evans	CEO	Sell	27,700	$83.80	$2,321,260.00
8/19/2021	John M Evans	CEO	Sell	20,000	$99.49	$1,989,800.00
7/7/2021	John M. Evans	CEO	Sell	25,000	$107.87	$2,696,750.00	1,046,525
7/6/2021	Graham K Cooper	Director	Sell	2,614	$120.61	$315,274.54
6/30/2021	Terry-Ann Burrell	CFO	Sell	30,000	$122.00	$3,660,000.00
6/28/2021	Giuseppe Ciaramella	Insider	Sell	78,580	$107.35	$8,435,563.00	123,341
6/28/2021	Graham K Cooper	Director	Sell	12,045	$106.34	$1,280,865.30	12,045
6/28/2021	Terry-Ann Burrell	CFO	Sell	45,000	$107.69	$4,846,050.00	69,809

Obama’s Forever Term [exposed]

From Porter & Company | Ad

America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.

Start streaming it now at no cost here

SEC Filings (Institutional Ownership Changes) for Beam Therapeutics (NASDAQ:BEAM)

99.68% of Beam Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Beam Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/8/2024	ProShare Advisors LLC	19,511	$0.65M	0.0%	+10.6%	0.024%
5/8/2024	Russell Investments Group Ltd.	143,828	$4.75M	0.0%	+4.4%	0.175%
5/8/2024	QRG Capital Management Inc.	23,036	$0.76M	0.0%	+45.2%	0.028%
5/7/2024	Reynders McVeigh Capital Management LLC	6,055	$0.20M	0.0%	N/A	0.007%
5/7/2024	Swiss National Bank	136,700	$4.52M	0.0%	+3.1%	0.166%
5/7/2024	SG Americas Securities LLC	6,124	$0.20M	0.0%	-58.7%	0.007%
5/3/2024	Nikko Asset Management Americas Inc.	2,361,817	$77.89M	0.8%	+0.2%	2.869%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	223,929	$6.78M	0.0%	+34.6%	0.272%
5/1/2024	Baillie Gifford & Co.	752,394	$24.86M	0.0%	-1.5%	0.914%
4/29/2024	Principal Financial Group Inc.	18,418	$0.61M	0.0%	+4.5%	0.022%
4/29/2024	China Universal Asset Management Co. Ltd.	15,919	$0.53M	0.1%	+64.7%	0.019%
4/26/2024	McGuire Investment Group LLC	6,250	$0.21M	0.0%	N/A	0.008%
4/24/2024	Krilogy Financial LLC	33,602	$1.11M	0.1%	+42.3%	0.041%
4/23/2024	Fishman Jay A Ltd. MI	10,000	$0.33M	0.0%	N/A	0.012%
4/19/2024	Sumitomo Mitsui Trust Holdings Inc.	2,361,817	$78.03M	0.1%	+0.2%	2.892%
4/18/2024	SteelPeak Wealth LLC	7,505	$0.25M	0.0%	N/A	0.009%
4/16/2024	Thrive Wealth Management LLC	6,925	$0.23M	0.0%	N/A	0.008%
4/13/2024	DLK Investment Management LLC	7,225	$0.24M	0.1%	N/A	0.009%
4/12/2024	Riverview Trust Co	796	$26K	0.0%	N/A	0.001%
3/22/2024	PNC Financial Services Group Inc.	1,564	$43K	0.0%	+144.0%	0.002%
3/11/2024	Vanguard Group Inc.	7,164,876	$195.03M	0.0%	+5.1%	8.774%
2/15/2024	Brandywine Managers LLC	8,067	$0.22M	0.2%	N/A	0.010%
2/13/2024	Rafferty Asset Management LLC	339,717	$9.25M	0.0%	-0.1%	0.417%
2/9/2024	D.A. Davidson & CO.	38,277	$1.04M	0.0%	+44.2%	0.047%
2/9/2024	UBS Group AG	260,500	$7.09M	0.0%	+118.2%	0.320%
2/9/2024	Dynamic Technology Lab Private Ltd	17,064	$0.46M	0.0%	N/A	0.021%
2/8/2024	Nikko Asset Management Americas Inc.	2,358,091	$64.09M	0.6%	+43.6%	2.893%
2/7/2024	QRG Capital Management Inc.	15,860	$0.43M	0.0%	+23.7%	0.019%
2/7/2024	Teacher Retirement System of Texas	15,466	$0.42M	0.0%	-16.0%	0.019%
2/7/2024	E Fund Management Co. Ltd.	18,174	$0.50M	0.0%	+4.0%	0.022%
2/6/2024	Charles Schwab Investment Management Inc.	571,236	$15.55M	0.0%	+5.5%	0.701%
2/6/2024	National Bank of Canada FI	1,500	$41K	0.0%	+200.0%	0.002%
2/6/2024	Vestmark Advisory Solutions Inc.	98,215	$2.67M	0.1%	N/A	0.121%
2/6/2024	Los Angeles Capital Management LLC	17,892	$0.49M	0.0%	-27.8%	0.022%
2/6/2024	First Horizon Advisors Inc.	994	$27K	0.0%	+125.9%	0.001%
2/6/2024	Swiss National Bank	132,600	$3.61M	0.0%	-6.9%	0.163%
2/5/2024	Victory Capital Management Inc.	9,282	$0.25M	0.0%	N/A	0.011%
2/2/2024	State of New Jersey Common Pension Fund D	84,061	$2.29M	0.0%	-20.9%	0.103%
2/1/2024	New York State Common Retirement Fund	28,626	$0.78M	0.0%	-3.4%	0.035%
2/1/2024	Handelsbanken Fonder AB	16,900	$0.46M	0.0%	+61.0%	0.021%
2/1/2024	Signaturefd LLC	1,021	$28K	0.0%	-61.9%	0.001%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	20,725	$0.56M	0.0%	+74.1%	0.025%
1/30/2024	Sumitomo Mitsui Trust Holdings Inc.	2,358,091	$64.19M	0.0%	+43.6%	2.893%
1/26/2024	Krilogy Financial LLC	23,617	$0.64M	0.1%	N/A	0.029%
1/26/2024	Baillie Gifford & Co.	764,123	$20.80M	0.0%	-12.7%	0.938%
1/25/2024	International Assets Investment Management LLC	68,050	$1.85M	0.0%	N/A	0.083%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	166,375	$4.53M	0.0%	-48.9%	0.204%
1/24/2024	International Assets Investment Management LLC	68,050	$1.85M	0.0%	N/A	0.083%
1/24/2024	China Universal Asset Management Co. Ltd.	9,667	$0.26M	0.1%	+325.5%	0.012%
1/17/2024	ARK Investment Management LLC	9,393,889	$255.70M	1.5%	+6.9%	11.526%
1/16/2024	Raymond James Financial Services Advisors Inc.	7,932	$0.22M	0.0%	N/A	0.010%
1/8/2024	Harbor Capital Advisors Inc.	34,918	$0.95M	0.2%	+13.0%	0.043%
1/5/2024	Green Alpha Advisors LLC	13,909	$0.38M	0.3%	-10.7%	0.017%
12/18/2023	Vanguard Group Inc.	6,814,970	$163.90M	0.0%	-2.8%	8.362%
12/6/2023	Citigroup Inc.	197,597	$4.75M	0.0%	+21.5%	0.242%
11/16/2023	Penserra Capital Management LLC	10,548	$0.25M	0.0%	+36.0%	0.013%
11/15/2023	Redmile Group LLC	1,469,725	$35.35M	1.7%	-1.0%	1.803%
11/15/2023	Seven Eight Capital LP	9,747	$0.23M	0.0%	N/A	0.012%
11/14/2023	Lazard Asset Management LLC	60,790	$1.46M	0.0%	-2.7%	0.075%
11/14/2023	Eventide Asset Management LLC	261,360	$6.29M	0.1%	-43.1%	0.321%
11/14/2023	Schonfeld Strategic Advisors LLC	77,072	$1.85M	0.0%	+2.9%	0.095%
11/14/2023	Corton Capital Inc.	20,505	$0.49M	0.2%	+91.9%	0.025%
11/14/2023	Teza Capital Management LLC	9,406	$0.23M	0.0%	N/A	0.012%
11/14/2023	Trexquant Investment LP	14,952	$0.36M	0.0%	N/A	0.018%
11/14/2023	Profund Advisors LLC	57,317	$1.38M	0.1%	+21.6%	0.070%
11/13/2023	Hsbc Holdings PLC	17,261	$0.42M	0.0%	-48.8%	0.021%
11/13/2023	ClariVest Asset Management LLC	15,150	$0.36M	0.0%	-60.0%	0.019%
11/13/2023	FMR LLC	6,497,831	$156.27M	0.0%	-9.0%	7.973%
11/13/2023	QRG Capital Management Inc.	12,825	$0.31M	0.0%	N/A	0.016%
11/13/2023	Rafferty Asset Management LLC	340,141	$8.18M	0.0%	+31.8%	0.417%
11/13/2023	Baillie Gifford & Co.	875,747	$21.06M	0.0%	+67.2%	1.075%
11/13/2023	DekaBank Deutsche Girozentrale	50,000	$1.20M	0.0%	-9.1%	0.061%
11/13/2023	E Fund Management Co. Ltd.	17,470	$0.42M	0.0%	+26.0%	0.021%
11/9/2023	Rhumbline Advisers	105,496	$2.54M	0.0%	+11.0%	0.133%
11/9/2023	Deutsche Bank AG	56,799	$1.37M	0.0%	+8.4%	0.072%
11/9/2023	Citigroup Inc.	197,597	$4.75M	0.0%	+21.5%	0.249%
11/9/2023	UBS Group AG	119,398	$2.87M	0.0%	-6.1%	0.151%
11/8/2023	State of New Jersey Common Pension Fund D	106,269	$2.56M	0.0%	+41.5%	0.134%
11/8/2023	State Board of Administration of Florida Retirement System	19,910	$0.48M	0.0%	+2.6%	0.025%
11/8/2023	Vanguard Personalized Indexing Management LLC	8,993	$0.22M	0.0%	N/A	0.011%
11/8/2023	Charles Schwab Investment Management Inc.	541,410	$13.02M	0.0%	+8.0%	0.684%
11/8/2023	D.A. Davidson & CO.	26,545	$0.64M	0.0%	+45.7%	0.034%
11/8/2023	Swiss National Bank	142,400	$3.43M	0.0%	+12.9%	0.180%
11/7/2023	Barclays PLC	197,647	$4.75M	0.0%	+36.7%	0.250%
11/7/2023	Jump Financial LLC	32,330	$0.78M	0.0%	+18.8%	0.041%
11/7/2023	Arizona State Retirement System	18,446	$0.44M	0.0%	+13.4%	0.023%
11/6/2023	Los Angeles Capital Management LLC	24,765	$0.60M	0.0%	-7.8%	0.031%
11/4/2023	Capula Management Ltd	38,100	$0.92M	0.0%	N/A	0.048%
11/4/2023	Signaturefd LLC	2,682	$65K	0.0%	+4,605.3%	0.003%
11/2/2023	Nisa Investment Advisors LLC	3,312	$80K	0.0%	+70.0%	0.004%
11/1/2023	Stonehage Fleming Financial Services Holdings Ltd	6,000	$0.14M	0.0%	N/A	0.008%
10/31/2023	Teacher Retirement System of Texas	18,418	$0.44M	0.0%	+17.2%	0.023%
10/31/2023	Allworth Financial LP	1,105	$27K	0.0%	+163.7%	0.001%
10/31/2023	China Universal Asset Management Co. Ltd.	2,272	$55K	0.0%	+84.0%	0.003%
10/30/2023	Sumitomo Mitsui Trust Holdings Inc.	1,642,180	$39.49M	0.0%	+35.1%	2.073%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	325,682	$7.83M	0.0%	+10.5%	0.411%
10/25/2023	Zurcher Kantonalbank Zurich Cantonalbank	11,907	$0.29M	0.0%	+15.0%	0.015%
10/24/2023	Bank of New York Mellon Corp	493,916	$11.88M	0.0%	+2.5%	0.624%
10/23/2023	Commonwealth Equity Services LLC	9,812	$0.24M	0.0%	+11.7%	0.012%
10/20/2023	Harbor Capital Advisors Inc.	30,913	$0.74M	0.2%	+18.4%	0.039%

Data available starting January 2016

Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 for the treatment of sickle cell disease or beta-thalassemia; and BEAM-302, a liver-targeting LNP formulation to treat severe alpha-1 antitrypsin deficiency; BEAM-201, an anti-CD7 CAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of refractory T-cell acute lymphoblastic leukemia/T cell lymphoblastic lymphoma; and BEAM-301, a liver-targeting LNP formulation for the treatment of glycogen storage disease 1a. The company has research collaboration agreement with Pfizer Inc., focus on in vivo base editing programs for targets rare genetic diseases of the liver, muscle, and central nervous system; Apellis Pharmaceuticals to conduct preclinical research on target specific genes within the complement system in various organs, including the eye, liver, and brain; Verve Therapeutics, Inc., for cardiovascular disease treatments; Sana Biotechnology, Inc., to research, develop, and commercialize rights to CRISPR Cas12b for cell therapy programs; and Orbital Therapeutics design RNA for the prevention, treatment or diagnosis of human disease. Beam Therapeutics Inc. was incorporated in 2017 and is based in Cambridge, Massachusetts.

Today's Range

Now: $22.24

$21.63

$22.27

50 Day Range

MA: $29.84

$21.22

$39.84

52 Week Range

Now: $22.24

$16.95

$49.50

Volume

1,020,204 shs

Average Volume

1,424,351 shs

Market Capitalization

$1.83 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.88

Who are the company insiders with the largest holdings of Beam Therapeutics?: Beam Therapeutics' top insider investors include:
Fmr Llc (Insider)
John M Evans (CEO)
Giuseppe Ciaramella (President)
Giuseppe Ciaramella (Insider)
Amy Simon (Insider)
Christine Bellon (Insider)
Terry-Ann Burrell (CFO)
Learn More about top insider investors at Beam Therapeutics.
Who are the major institutional investors of Beam Therapeutics?: Beam Therapeutics' top institutional shareholders include:
Sumitomo Mitsui Trust Holdings Inc. — 2.89%
Nikko Asset Management Americas Inc. — 2.87%
Baillie Gifford & Co. — 0.91%
Mirae Asset Global Investments Co. Ltd. — 0.27%
Russell Investments Group Ltd. — 0.17%
Swiss National Bank — 0.17%
Learn More about top institutional investors of Beam Therapeutics stock.
Which institutional investors are selling Beam Therapeutics stock?: During the previous quarter, BEAM stock was sold by these institutional investors:
Baillie Gifford & Co.
SG Americas Securities LLC
In the last year, company insiders that have sold Beam Therapeutics company stock include:
Fmr Llc (Insider)
John M Evans (CEO)
Giuseppe Ciaramella (President)
Giuseppe Ciaramella (Insider)
Amy Simon (Insider)
Christine Bellon (Insider)
Terry-Ann Burrell (CFO)
Learn More investors selling Beam Therapeutics stock.
Which institutional investors are buying Beam Therapeutics stock?: In the previous quarter, BEAM stock was bought by institutional investors including:
Mirae Asset Global Investments Co. Ltd.
Fishman Jay A Ltd. MI
Krilogy Financial LLC
SteelPeak Wealth LLC
DLK Investment Management LLC
QRG Capital Management Inc.
Thrive Wealth Management LLC
China Universal Asset Management Co. Ltd.